Core Viewpoint - SINTX Technologies, Inc. has successfully completed a private placement of common stock and warrants, raising approximately $5 million for working capital purposes [1][2]. Group 1: Private Placement Details - The company issued and sold 1,449,287 shares of common stock at a price of $3.45 per share, along with unregistered warrants to purchase an equal number of shares at an exercise price of $3.32 [1][2]. - The offering closed on February 25, 2025, and was facilitated by H.C. Wainwright & Co. as the exclusive placement agent [2]. Group 2: Securities Regulation - The securities were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933 and Regulation D, and have not been registered under the Act or applicable state securities laws [3]. - The company has agreed to file registration statements with the SEC for the resale of the shares and those issuable upon exercise of the warrants [3]. Group 3: Company Overview - SINTX Technologies is based in Salt Lake City, Utah, and specializes in advanced ceramics for medical applications, particularly silicon nitride, which has been implanted in humans since 2008 [5]. - The company has pursued strategic acquisitions and alliances to expand into new markets [5].